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CLINICAL ETHICS
A new prescription for empirical ethics research in pharmacy:
a critical review of the literature
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Empirical ethics research is increasingly valued in bioethics and
healthcare more generally, but there remain as yet under-
researched areas such as pharmacy, despite the increasingly
visible attempts by the profession to embrace additional roles
beyond the supply of medicines. A descriptive and critical
review of the extant empirical pharmacy ethics literature is
provided here. A chronological change from quantitative to
qualitative approaches is highlighted in this review, as well as
differing theoretical approaches such as cognitive moral
development and the four principles of biomedical ethics.
Research with pharmacy student cohorts is common, as is
representation from American pharmacists. Many examples of
ethical problems are identified, as well as commercial and legal
influences on ethical understanding and decision making. In this
paper, it is argued that as pharmacy seeks to develop
additional roles with concomitant ethical responsibilities, a new
prescription is needed for empirical ethics research in
pharmacy—one that embraces an agenda of systematic
research using a plurality of methodological and theoretical
approaches to better explore this under-researched discipline.
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T
his paper reviews the literature at the con-
fluence of two ethical subjects—one increas-
ingly valued and researched and the other still
relatively unexplored. Regarding the first, the use
of empirical ethics data and research methods
from the social sciences has gained respectability
and value both in the applied philosophical field of
bioethics and also in health services research
generally.1–3 Increasingly, empirical research is
believed to be important in mapping out the
ethical terrain of healthcare and there is a hope
that closer integration of empirical and normative
ethical study may be achieved, setting aside
traditional differences that originated in the ‘‘is–
ought’’ debate.4 As for the unexplored subjects,
although many empirical, and indeed normative,
ethical studies have been undertaken in the high
drama concerns of medicine and the pioneering
technologies of reproductive and genetic medicine,
other areas of healthcare such as pharmacy have
been relatively neglected. As Brazier5 notes,
‘‘…philosophers, social scientists and academic
lawyers continue to demonstrate a worrying
tendency to concentrate almost exclusively on
ethical dilemmas of high drama and low incidence
[…] The daily round of the pharmacist in hospital
or the community simply lacks that drama’’
(p xxii). Community pharmacists, in particular,
represent a point of access for patients and
customers to many services associated with med-
icines and healthcare advice. At the same time,
their roles are changing, and the traditional
activities of medicine preparation, dispensing and
over-the-counter sales have been augmented by
many additional services. In England, for example,
community pharmacists have a new contract with
the National Health Service and are being encour-
aged to undertake supplementary prescribing,
drug use reviews, near-patient diagnostic testing,
and the sale of an increasing number of de-
regulated, former prescription-only medicines such
as emergency hormonal contraception and statins.6
In a recent review on the scope of the international
ethics literature on pharmacy, Wingfield et al7
identified several concerns and omissions, includ-
ing a preponderance of scenario-based studies
from pharmacy practice and a paucity of sub-
stantive literature on ethics and values in phar-
macy. Wingfield et al did provide an example of
empirical ethics research but, because of specific
search dates, omitted other relevant empirical
studies. This paper aims to review the extant
empirical ethics literature in pharmacy, heeding
Marx’s8 advice that ‘‘…we are not only creators of
new knowledge, but protectors and transmitters of
old knowledge […] Seek an appropriate balance
between appreciation and advancement of the
literature’’ and also to identify opportunities for
further research. Three key areas emerge from the
review. Firstly, earlier studies typically used ques-
tionnaire-based quantitative methods but more
recently qualitative approaches have been adopted,
using focus groups and semistructured interviews.
Secondly, two dominant theories—principlism and
cognitive moral development—are identified and
explored as approaches to grounding empirical
research in normative philosophical and also
psychological theory, respectively. Thirdly, samples
have often included students and Anglophone,
especially American, pharmacists, and few studies
have focused on non-community pharmacy set-
tings such as secondary hospital care.
METHODS
Our study included searches of several electronic
databases, initially using combinations of the
following keywords: pharmacy, empirical, ethics,
ethical, dilemma and pharmacist. Databases
searched were Medline, EMBASE, ISI Web of
Abbreviations: CMD, cognitive moral development; DIT,
Defining Issues Test
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Knowledge, SOSIG and BIOME. Hand searches were also
carried out on specific journals such as The Pharmaceutical
Journal, International Journal of Pharmacy Practice, Journal of
Medical Ethics and Journal of Business Ethics. Exclusion criteria
included pharmaceutical industry or exclusively educational
research, normative applied ethical discussions, and studies
whose central aim was not related to ethical description or
evaluation. Furthermore, an internet search using the above
keywords was also undertaken using Google, in response to the
EMPIRE project into empirical bioethics research, which
recommended that ‘‘…it is also important to take into account
‘grey’ literature such as reports, PhD theses, and government
white/green papers’’(www.empire.konnu-nikation.aau.dk/
Part_A_final.pdf). Several additional studies, often conference
presentations, were identified using this search method. Table 1
gives details of the studies that were investigated.
EMPIRICAL ETHICS RESEARCH IN PHARMACY
Results
Having carried out searches in accordance with the method,
several relevant studies were identified and are listed in table 1. It
should be noted that the relatively prolific output of Latif included
the repeated use of one dataset, reported in many publications.
The number of distinct studies seems to be similar to other
relatively under-researched areas of healthcare such as general
medical practice, for example, where one literature review
identified only nine relevant empirical studies.29 Following
analysis of the identified empirical pharmacy ethics studies, many
important themes emerged and these will now be considered in
relation to methodology, ethical theory and samples.
Methodology and methods
A chronological change in research approach and method was
apparent over the 19-year period of identified empirical ethics
studies. Many of the earlier studies used a questionnaire that
contained hypothetical ethical scenarios from which respondents
selected options. This allowed statistical analysis of pharmacists’
ethical problems and reasoning, whereas almost all later studies
adopted interview or focus group methods. Typical of the first
approach was the earliest identified empirical ethics study, by
Lowenthal et al, that dealt with the attitudes of practising and
student pharmacists to ethical dilemmas, with the aim of
developing more appropriate undergraduate ethics teaching. A
postal questionnaire was used, which included questions that
required a simple yes or no response to a variety of hypothetical
dilemmas—dilemmas originating from the authors’ experiences
or from the normative literature. The study concluded that there
was broad attitudinal agreement among students and pharma-
cists in relation to many of the dilemmas posed, but some
disagreements did occur. The choice of relevant vignettes or
scenarios for questionnaires in empirical ethics research has been
Table 1 Summary of empirical ethics studies in pharmacy
Study Sample Methodology Design Aims/results
Lowenthal et al,9
Lowenthal10
55 US pharmacists,
165 US pharmacy
students
Quantitative Questionnaire Document pharmacy students’ attitudes to ethical dilemmas and
compare with pharmacists. Both have high levels of ethical
behaviour.
Dolinsky and Gottlieb11 170 US pharmacy
students
Quantitative Questionnaire To identify pharmacy students’ descriptions of moral dilemmas and
use of moral development theory.
Haddad12 869 practising US
pharmacists
Quantitative Postal questionnaire Compare incidence and difficulty of ethical problems and influencing
variables.
Latif and Berger13 113 US pharmacists Quantitative DIT Psychometric Test Pharmacy students scored higher on moral reasoning than
community pharmacists.
92 US students
Latif et al14 114 US community
pharmacists
Quantitative DIT Psychometric Test Community pharmacists’ moral reasoning and components of clinical
performance.
Latif15 113 US community
pharmacists
Quantitative DIT Ethical cognition, organisational reward systems and patient-focused
care.
Latif16 113 US community
pharmacists
Quantitative DIT Ethical cognition and selection-socialisation in retail pharmacy.
Latif17 114 US pharmacists Quantitative DIT Link between moral reasoning and patient care.
Latif18 Not stated Quantitative DIT A comparison of chain and independent pharmacists’ moral
reasoning.
Hibbert et al19 6 UK community
pharmacists
Qualitative Semistructured
interviews
Four principles and practical ethical reasoning found. Legal,
business, organisational concerns present.
Range of dilemmas spontaneously identified.
Latif20 113 US community
pharmacists
Quantitative DIT Psychometric Test
(postal)
Influence of pharmacists’ tenure on moral reasoning. Older
pharmacists scored lower.
Latif21 69 Canadian and73
US students
Quantitative DIT Psychometric Test Assess moral reasoning of pharmacy students. Unexplained national
variation.
Elwell and Bailie22 112 US pharmacy studentsQuantitative Questionnaire (3-point
scale)
Influence of class and clinical experience on ethical decisions was not
relevant for five ethical scenarios.
Wingfield et al23 40 UK pharmacy
students
Qualitative Focus group Perceptions of ethics among pharmacy students.
Latif24 1564 US pharmacy
students
Quantitative DIT Psychometric Test To measure and compare ethical reasoning of 1st-year and 3rd-year
pharmacy students and geographical differences.
Wingfield et al25 11 UK community
pharmacists (5 for
focus group)
Qualitative Focus group and
semistructured
interviews
Influence of company policy on ethical decision making. Policy
created concern but also guided ethical thinking.
Kalvemark et al26 5–7 Swedish hospital
pharmacists, dispensers
Qualitative Focus group Assess extent of moral distress in hospital doctors, nurses and
pharmacists. Time/recourse constraints, rule breaking, professional
conflict cause pharmacy distress.
Cooper27 11 UK community
pharmacists
Qualitative Semistructured
interviews
Ability of pharmacists to resolve ethical problems varied. Legal
controls, the commercial environment and professional isolation
precipitated a range of dilemmas.
Chaar et al28 25 Australian
pharmacists
Qualitative Semistructured
interviews
Common sense reasoning and best interests of patient identified as
central. Legal and business dilemmas in community common.
DIT, Defining Issues Test.
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identified as a concern in the business and medical ethics fields
and was also apparent in several of the pharmacy studies
identified.30 31 Haddad,12 for example, argued that this was due to
the lack of available empirical examples of ethical problems and,
using a questionnaire adapted from previous work on nursing
ethics, included 19 dilemmas that were selected on the basis of
their frequency in the normative pharmacy ethics literature,
rather than from practice. A free response section was included
for pharmacists to provide their own examples, but the study did
not indicate whether this section was used. Despite quantitative
studies being particularly suited to statistical analysis of variables
such as the frequency of ethical dilemmas, the study by Haddad
was the only one to investigate this. It was reported that 58% of
pharmacist respondents had encountered an ethical problem in
the last year but a third of pharmacists simply could not recall
when they were last associated with an ethical dilemma.
Quantitative and qualitative approaches have traditionally
been considered to occupy distinct and separate epistemological
territory, with one privileged over the other. However, this
review does not seek to perpetuate such a belief, but recognises
that the choice of research approach should be determined by
the type of question being asked. The quantitative studies
identified in this review, for example, often focused on specific
questions or sought to test hypotheses, whereas the qualitative
studies are more concerned with understanding and exploring
issues in depth or contextually. The chronological variation in
research approach is nonetheless apparent and appears to have
precluded study designs that triangulate and combine meth-
ods.33 More recent research has tended to use qualitative
approaches such as semistructured interviews or focus groups.
In the earliest identified study of this type, by Hibbert et al,19 the
authors used interviews to identify and explore the types of
dilemma encountered by community pharmacists and to gain
an understanding of pharmacists’ ethical awareness. The study
found a diversity of ethical influences on pharmacists,
including business values, ethical codes, organisational values
and ethical reasoning, which corresponded to many ethical
principles and also common sense. The qualitative studies
identified often offered a complex pattern of ethical pharmacy
practice. The study by Cooper, for example, found that a variety
of dilemmas and approaches to ethical reasoning were apparent
among pharmacists—evidenced often by intuitive reasoning
and examples that corresponded to a model of ethical decision
making that included identifying an ethical problem, using
ethical reasoning and also making an ethical decision.34
However, pharmacists’ ability to resolve ethical problems varied
and factors such as legal concerns, a sense of professional and
ethical isolation and the commercial environment seemed to be
inimical to developing ethical competency. As well as semi-
structured interview methods, some later qualitative studies
adopted focus group methods, with the advantage of allowing
data to be gathered quickly and easily, and using the interactive
aspects common to focus group studies.
Ethical theory
In addition to methodological differences between the studies
identified, many distinct theoretical approaches were also found
in relation to ethics, of both a normative and a psychological kind.
For example, although the study by Hibbert et al19 sought to
explore the diversity of ethical understanding, the subsequent
analysis of interview data included a comparison of pharmacists’
reasoning to only one particular, albeit popular, normative ethical
theory. Other values were considered, but the theoretical basis for
determining evidence of ethical understanding was based on the
principles of biomedical ethics developed by Beauchamp
and Childress.35 The study identified examples of each princi-
ple—autonomy, beneficence, non-maleficence and justice—
although the authors recognised the implied nature of such
inferences and noted that pharmacists did not mention these
principles explicitly. The study offered no support for the
assumption that the four-principles approach should be the
approach for ethical judgement except by reference to secondary
texts.35 A similar approach was favoured by Chaar et al,28 who
again, despite recognising the range of available ethical theories,
gave primacy to the four principles. In our study, no evidence of
justice or non-maleficence was found, but patients’ best interests
were identified as being influential. Although based on the
principles of biomedical ethics, neither study considered one of
the central aspects of the theory—the process of specification and
balancing of the principles. As Beauchamp and Childress make
clear in their work, it is not simply the recitation of the principles,
per se, but rather the coherentist reasoning in selecting a principle
in a particular healthcare situation that characterises their theory,
in a manner similar to Rawls’s36 reflective equilibrium. Both
studies found, however, that a range of value sets and common
sense appeared to be ethically influential for pharmacists.
In contrast with the normative ethical four-principles theory
used by Hibbert et al,19 a psychological theory was used in the
empirical pharmacy ethics studies by Dolinsky and Gottlieb11
and also Latif13. This related to cognitive moral development
(CMD), and these studies offer relatively detailed accounts of
the theory, identifying the work of Piaget,37 Kohlberg,38 and
Rest and Narvaez39 in the theory’s development. CMD is
concerned with the progression of people through various
mental stages of moral development over time, and Kohlberg
identified three levels of moral development (and two
substages of each level) relating to reasoning that could be
distinguished as (1) pre-conventional and involving reasoning
related to external punishment (stage one) or egoistic self-
interest (stage two); (2) conventional and appealing to
reasoning that considers our immediate peers (stage three)
and then broader social implications and laws (stage four); (3)
post-conventional and applying principled reasoning that
recognises the social contract (stage five); and (4) universal
ethical principles (stage six). The CMD theory has been used
extensively in many healthcare settings, and is claimed to have
validity in relation to predicting better clinical or professional
behaviour.40 41 The attraction of the theory for empirical
pharmacy research according to Latif13 is that CMD may be
regarded as a conceptual tool or skill and that ‘‘…individuals
with more advanced moral reasoning skills are often better able
to make sense of and resolve difficult moral and social
dilemmas’’ (p 167). However, Dolinsky and Gottlieb argue that
CMD may also be useful in clarifying and developing moral
understanding and that the authors use CMD in differing ways.
For Dolinsky and Gottlieb, CMD is primarily an analytical tool,
to ascribe developmental stages to the responses that pharmacy
students provided about ethical dilemmas, in a similar way to
that used by Kohlberg (who developed a moral judgement
interview that required participants to provide reasoned but
open responses to hypothetical questions that were subse-
quently stage coded); for Latif, the CMD theory is used in a
psychometric form called the Defining Issues Test (DIT)
developed by Rest.39 Using a self-completion questionnaire
format, Rest sought to make identifying moral reasoning both
easier and faster to administer, and to provide less potential
researcher bias by non-interpretative, pre-coded responses to
the dilemmas posed. The DIT is manifestly quantitative in
nature and often uses a calculation that assesses the percentage
of principled responses chosen over six (but possibly three)
hypothetical dilemmas—what is called the P% score. In
contrast with Kohlberg’s claim that people reason progressively
higher, Rest allows for reasoning across stages, and is
concerned with recognition and rating of pre-coded reasoning
as opposed to Kohlberg’s focus upon self-generated responses.
84 Cooper, Bissell, Wingfield
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However, no mention is made of such theoretical differences by
Latif.
The substantive content of Latif’s work has been covered in
some detail by Wingfield et al,7 but across several publications
he uses CMD and specifically the DIT instrument to explore the
community pharmacy environment and consider what may be
responsible for what he describes as the relatively low levels of
moral reasoning of practising pharmacists. Following this
initial finding, many subsequent hypotheses were considered
in further publications, including whether community phar-
macists’ level of moral reasoning would be, variously, positively
correlated to their clinical skills, or related to owner or
employee status and number of years practised. The study by
Dolinsky and Gottlieb11 appeared to offer evidence of principled,
stage-six reasoning, although the lack of empirical data to
support such a stage has raised concerns about this aspect of
Kohlberg’s theory.42 Latif does recognise several challenges to
CMD, and in particular identifies Gilligan’s criticism of
Kohlberg’s theory that justice-based reasoning neglects alter-
native moral approaches such as an ethics of care. Latif
explored evidence of specific gender differences, and found
that female pharmacists obtained ‘‘higher’’ DIT scores,
although Gilligan43 has subsequently argued that an ethics of
care represents simply a different, and not necessarily female,
voice. Latif also identifies several implications of CMD in his
work: (1) an economic saving could be made if pharmacists
develop more advanced moral reasoning skills; (2) that moral
reasoning be tested in the pharmacist recruitment process of
organisations; and (3) that litigation against pharmacists may
decrease in relation to the level of moral reasoning.
Samples
Having identified methodological and theoretical differences in
the empirical pharmacy ethics literature, another relevant theme
was the types of respondents or samples used in the various
studies. As table 1 indicates, differences in the samples relating to
nationality and student cohorts are apparent. Many of the studies
identified used American pharmacists and despite more recent
studies including UK, Swedish and Australian pharmacists, there
is under-representation in many areas of the world, which may
limit the scope of our comprehension of empirical ethical issues
across different healthcare systems and cultures. In addition, few
studies focused specifically on the hospital pharmacy setting, and
although Haddad12 and Chaar et al28 sampled pharmacists from all
areas of pharmacy practice, including academia, only the study by
Kalvemark et al26 focused on the hospital environment. It was also
the only study to include pharmacy dispensers and assistants.
More apparent was the use of student cohorts in the studies
identified, either solely or in comparison with practising
pharmacists. This may be explained by the fact that many
studies set out to inform the teaching of ethics at the
undergraduate level. Indeed, even studies that sought to
explore practising pharmacists’ understanding of ethics, such
as the study by Hibbert et al, also aimed to be of use in the
undergraduate pharmacy curriculum (Hibbert D, personal
communication, 2004). Although most studies valued the
ethical views of students by virtue of their not being practising
pharmacists, students in the study by Dolinsky and Gottlieb11
appeared to be used as proxies in relation to ethical dilemmas.
Students were asked to describe two dilemmas that included
altruism and self-interest but these could be drawn from either
first-person experience or what students recalled about the
dilemmas of other pharmacists. The authors concede that
‘‘…the inferred reasons for actions probably tells us more about
the pharmacy student doing the inferring than about the level
of moral judgment of the pharmacist’’ (p 57). By contrast, and
more transparently, the aim of the study by Wingfield et al that
included pharmacy students was simply to determine their
perceptions of pharmacy ethics, and they concluded that
exposure to practice (as students progress through the four-
year UK course) led to an increased awareness and under-
standing of ethical issues.23 Despite the direct pedagogical aims
of some studies, it may also be argued that student cohorts are
used partly because they represent an easier research group to
recruit and investigate, and are, in effect, a convenience sample.
They are usually logistically, financially and temporally easier,
as they may be closer to the researcher on campus, require less
remuneration (if any) for participating, and also have perhaps
more time to spare in comparison with practising pharmacists.
Dilemmas and themes
Having so far offered a critical review of the empirical ethics
literature in pharmacy in terms of methodology, theory and
sampling, the actual results of these studies and advances in
knowledge that they have generated must not be ignored. What
was evident from many of the studies was that the pharmacy
environment seemed to be important in terms of shaping the
types of ethical dilemmas or problems encountered and also
relevant in terms of influencing the ethical reasoning of the
pharmacist. This appeared to be especially important for
community pharmacy, and Chaar et al noted that problems
occurred more often in the community setting than in other
areas of pharmacy practice. Haddad similarly identified more
ethical problems in the community setting but also found that
actual work experience shaped pharmacists ethically. By
contrast, Latif’s work repeatedly suggested that the community
pharmacy environment was detrimental to moral reasoning—
pharmacists who had remained in practice longer tended to
have lower moral reasoning scores and there were also some
differences between scores for independent pharmacists and
those who were employees; pharmacy students, who had not
been exposed to the community pharmacy environment, also
scored higher. However, the qualitative studies in this literature
review provide a more complex picture of ethical influence. For
example, Wingfield et al25 found that although business and
commercial values led to ethical issues such as controlling
profit and customer pressure, company and organisational
policies were also helpful in terms of dealing with ethically
problematic issues and in ‘‘guiding their thinking in difficult
areas such as supply of emergency hormonal contraception’’.
The pharmacists interviewed by Hibbert et al appeared to be
even more variously influenced—by self-interest, commercial
and organisational values, and also legal concerns. The study
also offered a considerable number of pharmacist-generated
ethical concerns that provide a wealth of information about UK
community pharmacy and that, for example, pharmacists often
have to deal with patient representatives and encounter
confidentiality issues; regulations relating to emergency sup-
plies and controlled drugs lead to conflicts between benefiting
the patient and complying with legal requirements; supplying
syringes to addicts to prevent health risks must be balanced by
a concern about theft from the pharmacy; and that the code of
ethics was not often referred to. The study by Cooper identified
similar concerns among UK pharmacists, along with additional
commercial ethical dilemmas relating to charging for mon-
itored dosage systems, branded medicine substitution, pressure
to link-sell medicines, concern for customer poverty and selling
confectionery. In the study by Kalvemark et al,26 Swedish
pharmacists appeared to experience moral stress from issues
that were related to time pressures in a hospital dispensary and
to staff shortages. Similar concerns emerged in the study by
Hibbert et al, in that pharmacists expressed concern about
challenging prescribing doctors because of the perception of
professional hierarchy and also having to balance breaking a
regulation to benefit a patient.
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CONCLUSIONS
What conclusions may be drawn from this review of the empirical
ethics literature in pharmacy? Apparently, this is still a relatively
under-researched area of healthcare ethics and many questions
remain unanswered. For example, it was reported that a third of
pharmacists sampled in one study could not remember when
they last encountered an ethical dilemma, but further research is
needed to explore this finding, perhaps in relation to concepts
such as ethical attention.44 The dominance of CMD and the ‘‘four-
principles’’ approach to ethical theory in the studies identified
may be explained by their popularity, but do these adequately
reflect how pharmacists make ethical decisions? The importance
of other ethical theories such as narratives, virtue ethics and
casuistry has been identified in relation to other healthcare
professionals and may be relevant to pharmacy.45 No systematic
programme of research seems to have been attempted and this
has meant that certain difficulties have emerged. For example,
earlier quantitative studies encountered problems in relation to
the selection of authentic dilemmas, whereas arguably the
appropriate use of qualitative approaches may have identified
ethical problems or dilemmas. As Cribb and Barber46 conclude in
relation to how research can facilitate the development of ethical
understanding and values in pharmacy: ‘‘… it would be advisable
to foster a coordinated programme of interdisciplinary research
studies in the field. This would allow for the benefits of multiple
perspectives while avoiding some of the problems of repetition or
fragmentation.’’ The absence of a dedicated ethics journal for
pharmacy (unlike many other healthcare professions) may be
relevant, and is possibly detrimental to research and its effective
dissemination and discussion. Moreover, the identification of
several relevant, non-published studies indicates that attention
should also be given to the ‘‘grey’’ literature to further inform
understanding in pharmacy but also in healthcare ethics, more
generally. Despite the recent use of qualitative approaches, no
studies on ethnography or participant observation were identi-
fied. This may be compared with other areas of healthcare, where
ethnographic research has increasingly been undertaken—to
increase understanding in that area of healthcare generally but
also allow ethical issues to be understood more clearly as the basis
for normative study.47–49
In relation to future studies, then, it is hoped that a new
prescription can be written for empirical ethics research in
pharmacy—one that encourages more research and also
coordinates it and considers where a range of theoretical
insights and research methods may be beneficial in exploring
this under-researched discipline.
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